Mark D'onofrio, MD
Orthopaedic Surgery · Lancaster, OHNPI 1316925811
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $121,903 of the $158,646 with a category attached, or 76.8%. 31 manufacturers reported payments, led by Signature Orthopaedics USA Corp at 59.2% of the total. 2025 is the largest year on record at $62,433, more than ten times the $2,203 reported in 2019. Among orthopaedic surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 109 payments — averaging $1455.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Signature Orthopaedics USA Corp$94K
- FX Shoulder Solutions, Inc$30K
- Globus Medical$26K
- Corentec America Inc$5K
- Ortho Development Corporation$3K
- Maxx Orthopedics, Inc.$163
- plus $1K from 25 others
What the payments were for
- Royalty or licence$121,90377%
- Consulting fees$21,46314%
- Speaking & faculty fees$3,6002%
- Travel & lodging$7,2435%
- Food & beverage$4,4373%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Signature Orthopaedics USA Corp | 5 | $93,900 |
| FX Shoulder Solutions, Inc | 8 | $29,637 |
| Globus Medical | 24 | $26,360 |
| Corentec America Inc | 8 | $4,703 |
| Ortho Development Corporation | 13 | $2,743 |
| Maxx Orthopedics, Inc. | 2 | $163 |
| Catalyst Orthoscience | 1 | $101 |
| Heron Therapeutics, Inc. | 6 | $90 |
| Stimwave Technologies Incorporated | 1 | $85 |
| Endo Pharmaceuticals Inc. | 5 | $75 |
| Abbott | 3 | $74 |
| Nextstep Arthropedix, LLC | 1 | $68 |
| Pacira Therapeutics, Inc. | 4 | $63 |
| Johnson & Johnson | 1 | $61 |
| Convatec Inc. | 3 | $52 |
| Pacira Pharmaceuticals Incorporated | 2 | $50 |
| Shalby Advanced Technologies, Inc. | 1 | $50 |
| Orthofix Medical, Inc. | 3 | $39 |
| Smith+Nephew | 2 | $36 |
| COSA Medical, LLC | 1 | $33 |
| Avanos Medical | 2 | $31 |
| AbbVie | 1 | $30 |
| Bioventus LLC | 2 | $30 |
| Heraeus Medical, LLC. | 2 | $29 |
| Ferring Pharmaceuticals Inc. | 2 | $27 |
| Endo USA, Inc. | 1 | $25 |
| Si-bone, Inc. | 1 | $23 |
| Vertex | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Genflex2 Total Knee System$11,138
- Legacy Stelkast Knee$6,354
- Corentec$4,703
- humelock reversed shoulder$3,052
- ACTIFY 3D$1,894
- Cementless Knee$675
- Joints$597
- ExcelsiusGPS Robotic Navigation System$367
- Balanced Knee Revision System$152
- BKS Revision II$107
- Archer CSR Total Shoulder System$101
- Archer R1 Reverse Shoulder System$101
How this compares
$158,646 in reported general payments places this provider in the 95th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 35 | $6,809 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 611 | $3,935 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 627 | $3,726 |
| Cephalexin | 201 | $971 |
| Gabapentin | 191 | $840 |
| Oxycodone Hcl | 140 | $720 |
| Methylprednisolone | 109 | $708 |
| Hydromorphone Hcl | 143 | $241 |
| Tramadol Hcl | 110 | $200 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 42 | $196 |
| Ibuprofen | 20 | $155 |
| Meloxicam | 57 | $148 |
| Promethazine Hcl | 84 | $134 |
| Tizanidine Hcl | 17 | $110 |
| Celecoxib | 13 | $108 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $61 | $6,80935 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 794 orthopaedic surgery providers in Ohio.
Other orthopaedic surgery in Lancaster
- Reuben GobezieCleveland$12M
- Gregory BerletWorthington$9.6M
- Wael BarsoumCleveland$8.9M
- Brian CohenChillicothe$8.8M
- Joseph IannottiCleveland$7.1M
- John SontichYoungstown$3.6M
- Anthony MiniaciCleveland$3.1M
- David WelkerMiamisburg$2.8M
- Kenneth GreeneCleveland$2.6M
- Mark FroimsonCleveland$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.